DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
BIIB021 is an investigational drug.
There have been 7 clinical trials for BIIB021. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Breast Neoplasms, Gastrointestinal Stromal Tumors, and Leukemia, Lymphoid. The leading clinical trial sponsors are Biogen and [disabled in preview].
Recent Clinical Trials for BIIB021
|Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding||Biogen||Phase 2|
|Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors||Biogen||Phase 1|
|An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)||Biogen||Phase 2|